Press Release: Basilea reports preliminary operating profit for 2022, significantly above guidance

-- Successful implementation of strategic decision to focus on anti-infectives and stronger than expected revenue lead to profitability earlier than anticipated Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, January 24, 2023 Basilea Pharmaceutica Ltd (SIX: BSLN), a......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Tuesday, 24 January
Share |